Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30275311.
- Also identified by DOI 10.1073/pnas.1806796115 and PMC identifier 6196530.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Haploinsufficiency of <i>Retinoic Acid Induced 1</i> (<i>RAI1</i>) causes Smith-Magenis syndrome (SMS), a syndromic autism spectrum disorder associated with craniofacial abnormalities, intellectual disability, and behavioral problems. There is currently no cure for SMS. Here, we generated a genetic mouse model to determine the reversibility of SMS-like neurobehavioral phenotypes in <i>Rai1</i> heterozygous mice. We show that normalizing the Rai1 level 3-4 wk after birth corrected the expression of genes related to neural developmental pathways and fully reversed a social interaction deficit caused by <i>Rai1</i> haploinsufficiency. In contrast, <i>Rai1</i> reactivation 7-8 wk after birth was not beneficial. We also demonstrated that the correct Rai1 dose is required in both excitatory and inhibitory neurons for proper social interactions. Finally, we found that <i>Rai1</i> heterozygous mice exhibited a reduction of dendritic spines in the medial prefrontal cortex (mPFC) and that optogenetic activation of mPFC neurons in adults improved the social interaction deficit of <i>Rai1</i> heterozygous mice. Together, these results suggest the existence of a postnatal temporal window during which restoring Rai1 can improve the transcriptional and social behavioral deficits in a mouse model of SMS. It is possible that circuit-level interventions would be beneficial beyond this critical window.
Medical subject headings
- Disease Models, Animal
- Haploinsufficiency
- Interpersonal Relations
- Smith-Magenis Syndrome
- Social Behavior Disorders
- Trans-Activators